ID.1
Item
to be included in this study, you must meet the following criteria:
boolean
Locally advanced breast cancer | Carcinoma breast stage IV
Item
locally advanced or metastatic breast cancer
boolean
C3495949 (UMLS CUI [1])
C0278488 (UMLS CUI [2])
Measurable Disease
Item
measurable disease as per recist criteria
boolean
C1513041 (UMLS CUI [1])
Prior Chemotherapy Carcinoma breast stage IV
Item
no prior chemotherapy in the metastatic breast setting
boolean
C1514457 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
Prior Chemotherapy Early-Stage Breast Carcinoma | Hormone Therapy Early-Stage Breast Carcinoma
Item
prior chemotherapy and/or hormonal therapy for early stage breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C2986665 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C2986665 (UMLS CUI [2,2])
Herceptin Adjuvant
Item
adjuvant herceptin is allowed
boolean
C0338204 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
prior radiation therapy Carcinoma breast stage IV | prior radiation therapy Early-Stage Breast Carcinoma
Item
prior radiation therapy in either the metastatic or early stage setting
boolean
C0279134 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C2986665 (UMLS CUI [2,2])
Hormone Therapy Quantity
Item
patients may have received any number of hormonal therapies
boolean
C0279025 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
Gender
Item
only women are eligible for the study
boolean
C0079399 (UMLS CUI [1])
Performance of activities of daily living Ability | Assistance Minimal
Item
able to perform activities of daily living with minimal assistance
boolean
C1821398 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C0557034 (UMLS CUI [2,1])
C0547040 (UMLS CUI [2,2])
organ function | Bone Marrow function
Item
normal organ and bone marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
trastuzumab | Cardiac function
Item
patients who will be receiving trastuzumab must have normal heart function
boolean
C0728747 (UMLS CUI [1])
C0232164 (UMLS CUI [2])
Informed consent
Item
sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
you cannot participate in this study if any of the following apply to you:
boolean
C2348568 (UMLS CUI [1])
Prior Chemotherapy Carcinoma breast stage IV
Item
received prior chemotherapy for metastatic breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
Leptomeningeal Carcinomatosis
Item
known leptomeningeal carcinomatosis
boolean
C0220654 (UMLS CUI [1])
Metastatic malignant neoplasm to brain Uncontrolled
Item
uncontrolled brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Intercurrent disease Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0277557 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Malignant Neoplasms | Breast Carcinoma
Item
history of other non-breast cancer malignancy
boolean
C0006826 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
Prior Chemotherapy Early-Stage Breast Carcinoma
Item
received prior chemotherapy for early stage breast cancer within 6 months
boolean
C1514457 (UMLS CUI [1,1])
C2986665 (UMLS CUI [1,2])
criteria Additional | Study Subject Participation Status
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2])